Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001123292-14-000301)

Filing Details

Accession Number:: 0001123292-14-000301
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-03-10 19:38:21
Reporting Period:: 2014-03-06

Filing Date:: 2014-03-10
Accepted Time:: 2014-03-10 19:38:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1386858	Hyperion Therapeutics Inc	HPTX	Pharmaceutical Preparations (2834)	611512713

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1554403	A Christine Nash	C/O Hyperion Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA 94005	Svp & Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-03-06	15,000	$1.28	20,098	No	4	M	Direct
Common Stock	Disposition	2014-03-06	5,000	$29.03	15,098	No	4	S	Direct
Common Stock	Disposition	2014-03-06	100	$30.05	14,998	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2014-03-06	15,000	$0.00	15,000	$1.28

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
26,157		2019-11-02	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2013.
This option is fully vested and immediately exercisable.